The Centre for Clinical Practice develops clinical guidelines which form recommendations on the appropriate treatment and care of people with specific diseases and conditions within the NHS. They are based on the best available evidence. Guidelines help health professionals in their work, but they do not replace their knowledge and skills
NICE public health guidance makes recommendations for England on what is known from research and practice about the effectiveness and cost effectiveness of interventions and broader programmes, including the systems in which they are delivered, and the methods used to deliver them.
NICE public health guidance is relevant to health professionals working in clinical and community settings, and commissioners, managers and team leaders with responsibility for health improvement in the NHS, local authorities, schools, and public, private and voluntary sectors. It is also relevant to people interested in improving their own health or the health of their children or other people they care for, and to the wider community.
|Scoping workshop:||12 November 2012|
|Consultation on draft scope with stakeholders:||29 November 2012 - 10 January 2013|
|Consultation on draft guideline with stakeholders:||18 May - 30 June 2015|
|Publication date:||October 2015|
|Centre for clinical practice lead:||Sarah Willett|
|Communications manager:||Phil Ranson|
|Guidelines commissioning manager:||
|Guidelines coordinator:||Paula O'Grady|
|Patient involvement lead:||Erin Whittingham|
|Implementation lead:||Louisa Regan|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process.|
The Centre for Public Health (CPH) is currently carrying out a call for evidence to enable stakeholders to submit any information that may be relevant to the CPH team at NICE to inform it’s evidence reviews. The CPH is particularly interested in receiving information on any studies that are in-progress, unpublished, in-press or that have recently been published, or grey literature that relates to the review areas and questions outlined in the final scope.
For more information and to access the forms for evidence submissions, please visit the call for evidence webpage.